Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEIBA for Post-CPB Hemostasis in Pediatric Cardiac Patients
NCT05020483Phase 2Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of anti-inhibitor coagulant complex in postoperative hemorrhage, sponsored by Mayo Clinic. Planned start Oct 2021; status: withdrawn.
02
Drugs
anti-inhibitor coagulant complex
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT05020483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020483.